Catherine M. Verfaillie

Leuven Institute for Fertility and Embryology

Papers

1

Total Citations

14

H-Index

1

About

Catherine M. Verfaillie is a pioneering stem cell biologist whose groundbreaking work has reshaped our understanding of adult stem cell plasticity and regenerative medicine. Her most celebrated contribution is the discovery and characterization of multipotent adult progenitor cells (MAPCs), a rare population of adult stem cells capable of differentiating into cell types from all three germ layers—a finding that challenged long-held dogma about the limited potential of adult stem cells. This seminal work, published in *Nature* and *Science* in the early 2000s, has garnered thousands of citations and opened new avenues for cell-based therapies. Verfaillie’s research spans stem cell biology, tissue engineering, and translational medicine, with a particular focus on developing scalable manufacturing approaches for therapeutic cells. Her recent work on robotics-driven production of cartilaginous microtissues for skeletal repair exemplifies her commitment to bridging lab discoveries with clinical applications. A recipient of numerous honors, including election to the Royal Academy of Medicine of Belgium, Verfaillie’s legacy lies in her relentless pursuit of stem cell-based solutions for degenerative diseases, inspiring a generation of researchers to explore the hidden potential of adult tissues.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Robotics-Driven Manufacturing of Cartilaginous Microtissues for Skeletal Tissue Engineering Applications
14 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Leuven Institute for Fertility and Embryology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago